bibliographic entry 2020082 [be/2020082]
https://w3id.org/oc/corpus/be/2020082

is a
content
  • Garber A, Henry RR, Ratner R, Hale P, Chang CT, et al (2011) Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes. Diabet Obes Metab 13: 348–356.
references